Search Results 841-850 of 15950 for 78%
A Phase Ⅲ Study Of Rilvegostomig In Combination With Fluoropyrimidine And Trastuzumab Deruxtecan As The First-line Treatment For HER2-positive Gastric Cancer.
2016 Jul 1; 311 (1):F78-84 Epub 2016 May 11. View PubMed; Zhang Z, Lyon TD, Kadow BT, Shen B, Wang J, Lee A, Kang A, Roppolo JR, de Groat WC, Tai C ...
2020 Aug; 272(2):e75-e78. View PubMed; Moonsamy P, Axtell AL, Ibrahim NE, Funamoto M, Tolis G, Lewis GD, D'Alessandro DA, Villavicencio MA. Survival After ...
77 · 78 · 79 ... Next · Last · Sign up to receive email notifications. Explore more topics. Scroll backwards. Biotherapeutics · Clinical Trials · Discovery ...
Dr. Halena Gazelka 00:57. Welcome, everyone to Mayo Clinic Q&A. I'm Dr. Halena Gazelka. We're recording this podcast on April the 19th, 2021.
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
Doctors who perform this procedure · Narrow your search · Displaying 1-10 out of 78 doctors available ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Rochester, Minn., Jacksonville, Fla. The goal of this study is to provide access to axicabtagene ciloleucel for patients diagnosed with a disease approved for ...
1996 Nov 1; 78 (9):1888-91. View PubMed; Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.